Item Type | Name |
Concept
|
Brain Tissue Transplantation
|
Concept
|
Blood-Brain Barrier
|
Concept
|
Brain Ischemia
|
Concept
|
Brain
|
Concept
|
Deep Brain Stimulation
|
Concept
|
Brain Injuries
|
Concept
|
Brain Stem
|
Concept
|
Brain Chemistry
|
Concept
|
Brain-Derived Neurotrophic Factor
|
Academic Article
|
Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease.
|
Academic Article
|
Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.
|
Academic Article
|
Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient.
|
Academic Article
|
Knockout of p75NTR does not alter the viability of striatal neurons following a metabolic or excitotoxic injury.
|
Academic Article
|
Neurotrophic factor therapy for Parkinson's disease.
|
Academic Article
|
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.
|
Academic Article
|
Chronic ischemic stroke model in cynomolgus monkeys: behavioral, neuroimaging and anatomical study.
|
Academic Article
|
Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease.
|
Academic Article
|
Age-related alterations in GABA(A) receptor subunits in the nonhuman primate hippocampus.
|
Academic Article
|
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
|
Academic Article
|
Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements.
|
Academic Article
|
Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates.
|
Academic Article
|
In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.
|
Academic Article
|
Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism.
|
Academic Article
|
Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease.
|
Academic Article
|
Celebrating neural repair.
|
Academic Article
|
Gene therapy for Huntington's disease.
|
Academic Article
|
Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.
|
Academic Article
|
Transplanted dopaminergic neurons develop PD pathologic changes: a second case report.
|
Academic Article
|
Deep brain stimulation for treatment of obesity in rats.
|
Academic Article
|
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
|
Academic Article
|
Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease.
|
Academic Article
|
Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy.
|
Academic Article
|
Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.
|
Academic Article
|
Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.
|
Academic Article
|
Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys.
|
Academic Article
|
Postmortem study of deep brain stimulation of the anterior thalamus: case report.
|
Academic Article
|
Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys.
|
Academic Article
|
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.
|
Academic Article
|
Neural repair strategies for Parkinson's disease: insights from primate models.
|
Academic Article
|
Trophic factors therapy in Parkinson's disease.
|
Academic Article
|
Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.
|
Academic Article
|
Misfolded proteins in Huntington disease fetal grafts: further evidence of cell-to-cell transfer?
|
Academic Article
|
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
|
Academic Article
|
Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
|
Academic Article
|
Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats.
|
Academic Article
|
Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease.
|
Academic Article
|
Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease.
|
Academic Article
|
Fetal grafts for Parkinson's disease: Decades in the making.
|
Academic Article
|
Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
|
Academic Article
|
Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
|
Academic Article
|
a-Synuclein nonhuman primate models of Parkinson's disease.
|
Academic Article
|
Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
|
Academic Article
|
In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain.
|
Academic Article
|
Kinetic modeling and occupancy measures of the norepinephrine transporters in baboons using single photon emission computed tomography with (123)I-INER.
|
Academic Article
|
Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
|
Academic Article
|
Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease.
|
Academic Article
|
Analysis of age-related changes in psychosine metabolism in the human brain.
|
Academic Article
|
Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
|
Academic Article
|
Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms.
|
Academic Article
|
Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.
|
Academic Article
|
Loss of One Engrailed1 Allele Enhances Induced a-Synucleinopathy.
|
Academic Article
|
Temporal evolution of microglia and a-synuclein accumulation following foetal grafting in Parkinson's disease.
|
Academic Article
|
Focused ultrasound opening of the blood-brain barrier for treatment of Parkinson's disease.
|
Academic Article
|
Spreading of alpha-synuclein - relevant or epiphenomenon?
|
Academic Article
|
Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.
|
Academic Article
|
T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease.
|
Academic Article
|
Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease.
|
Academic Article
|
GDNF signaling in subjects with minimal motor deficits and Parkinson's disease.
|
Academic Article
|
Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brain.
|
Academic Article
|
In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain.
|
Academic Article
|
Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis.
|
Academic Article
|
Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.
|